Litigation Details for Foundation Medicine, Inc. v. Guardant Health, Inc. (D. Del. 2017)
✉ Email this page to a colleague
Foundation Medicine, Inc. v. Guardant Health, Inc. (D. Del. 2017)
| Docket | ⤷ Try a Trial | Date Filed | 2017-06-23 |
| Court | District Court, D. Delaware | Date Terminated | 2018-07-13 |
| Cause | 35:0145 | Assigned To | Leonard Philip Stark |
| Jury Demand | Both | Referred To | Christopher J. Burke |
| Parties | FOUNDATION MEDICINE, INC. | ||
| Patents | 9,340,830 | ||
| Attorneys | Trevor J. Quist | ||
| Firms | Farnan LLP | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Foundation Medicine, Inc. v. Guardant Health, Inc.
The biologic drug covered by the patent cited in this case is ⤷ Try a Trial .
Details for Foundation Medicine, Inc. v. Guardant Health, Inc. (D. Del. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-09-12 | that the claims of United States Patent No. 9,340,830 (the "'830 patent") requires an analysis of a tumor… cells (such as Guardant360) infringes the '830 patent.")) The issue does not appear to be as clear-cut…2017 13 July 2018 1:17-cv-00807 830 Patent Both District Court, D. Delaware | External link to document | ||
| 2016-05-17 | 1 | of United States Patent No. 9,340,830 (“the ’830 patent”) arising under the patent laws of the United…United States Patent and Trademark Office duly and legally issued U.S. Patent No. 9,340,830, entitled “…of the ‘830 patent are valid and enforceable. A true and correct copy of the ’830 patent is attached …claim of the ’830 patent. C. GUARDANT’S KNOWLEDGE OF THE PATENT-IN-SUIT … 30. Guardant cited the ’830 patent application in its patent application numbers 14861989 (information | External link to document | |
| 2018-02-14 | 138 | of the patent-in-suit, United States Patent No. 9,340,830. (D.I. 130) The United States Patent and Trademark…Trademark Office's ("PTO") Patent Trial and Appeal Board ("PTAB") instituted…IPR with respect to all asserted claims of the patents-in-suit, for similar reasons). Additionally, if…deposition-including four of the named inventors of the asserted patent." (Id.) …2017 13 July 2018 1:17-cv-00807 830 Patent Both District Court, D. Delaware | External link to document | |
| 2018-07-23 | 141 | Patent/Trademark Report to Commissioner of Patents | the Commissioner of Patents and Trademarks for Patent/Trademark Number 9,340,830. (etg) (Entered: 07/…2017 13 July 2018 1:17-cv-00807 830 Patent Both District Court, D. Delaware | External link to document |
| 2017-04-18 | 76 | interest in and to U.S. Patent No. 9,340,830 (the "'830 patent"). 55. …violated any of the patent laws of the United States with respect to the '830 Patent. Guardant further… One or more claims of the '830 Patent (the "Patent-in-Suit") are invalid pursuant …the United States Patent and Trademark Office during the prosecutions of the Patents-in- Suit, and …claim of the '830 patent. THE PATENT-IN-SUIT 57. | External link to document | |
| 2017-05-19 | 88 | infringement of U.S. Patent No. 9,340,830 (the “’830 Patent). The ’830 Patent is entitled “Optimization…830 Patent was filed on December 29, 2011 and the patent issued on May 17, 2016. The ’830 Patent claims…It is a ‘bedrock principle’ of patent law that ‘the claims of a patent define the invention to which …how the U.S. Patent and Trademark Office (“PTO”) and the inventor understood the patent. Phillips, 415…application for the patent was filed. Id. at 2130. As it is a challenge to the validity of a patent, the failure | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
